SEC Filing Details
Document Details
Form
Filing Date
Dec 21, 2018
Document Date
Dec 20, 2018
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
CRISPR Therapeutics
Issuer
CRISPR Therapeutics AG
Filer
Vertex Pharmaceuticals (Europe) Ltd